Quantum BioPharma, a biopharmaceutical company listed on NASDAQ (QNTM), is committed to developing innovative solutions for neurodegenerative and metabolic disorders, including alcohol misuse disorders. Their subsidiary, Lucid Psycheceuticals Inc., focuses on advancing Lucid-MS, a novel compound that has demonstrated efficacy in preventing and reversing myelin degradation, a key factor in multiple sclerosis. Additionally, Quantum BioPharma […]
Category: Contract Research Organization (CRO)
QPS Celebrates 30 Years of Excellence
QPS, a global Contract Research Organization (CRO), marks 30 years of providing top-tier discovery, bioanalysis, preclinical, and clinical drug development services. Starting as a bioanalysis shop in 1995, QPS has evolved into a full-service CRO with over 1,200 employees across the US, Europe, Asia, and Australia. Specializing in pharmacology, DMPK, toxicology, bioanalysis, and more, QPS […]
